Anaplastic Large Cell Lymphoma
Showing NaN - NaN of 9
Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)
Terminated
- Hodgkin Lymphoma
- +2 more
- brentuximab vedotin
-
Anaheim, California
- +18 more
Dec 6, 2022
Anaplastic Large Cell Lymphoma, Peripheral T Cell Lymphoma, Extranodal NK/T-cell Lymphoma Trial in Duarte, Nashville, Houston
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
-
Duarte, California
- +3 more
Jul 21, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +4 more
-
Atlanta, Georgia
- +2 more
Jul 25, 2018
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +45 more
- anti-endosialin/TEM1 monoclonal antibody MORAb-004
- +2 more
-
Birmingham, Alabama
- +19 more
Jan 7, 2016
Anaplastic Large Cell Lymphoma Trial in Houston (Cyclophosphamide, Doxorubicin HCl, vincristine sulfate)
Terminated
- Anaplastic Large Cell Lymphoma
- Cyclophosphamide
- +4 more
-
Houston, TexasM D Anderson Cancer Center
May 29, 2014
Anaplastic Large Cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Chicago,
Completed
- Anaplastic Large Cell Lymphoma
- +5 more
-
Chicago, Illinois
- +1 more
May 7, 2014
Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (XmAb2513)
Completed
- Hodgkin Lymphoma
- Anaplastic Large Cell Lymphoma
- XmAb2513
-
Chicago, Illinois
- +3 more
Apr 18, 2014
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +61 more
- bevacizumab
- cediranib maleate
-
Houston, TexasM D Anderson Cancer Center
Feb 14, 2014